Commerzbank Aktiengesellschaft’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,000
Closed -$449K 277
2020
Q1
$449K Hold
20,000
0.02% 280
2019
Q4
$287K Hold
20,000
﹤0.01% 618
2019
Q3
$106K Sell
20,000
-24,400
-55% -$2.72M ﹤0.01% 795
2019
Q2
$771K Buy
44,400
+24,400
+122% +$2.87M 0.01% 664
2019
Q1
$347K Buy
+20,000
New +$2.43M ﹤0.01% 691
2018
Q3
Sell
-15,000
Closed -$39K 1017
2018
Q2
$39K Hold
15,000
﹤0.01% 903
2018
Q1
$20K Hold
15,000
﹤0.01% 921
2017
Q4
$61K Buy
+15,000
New +$1.28M ﹤0.01% 873
2016
Q1
Sell
-70,000
Closed -$5.9M 1097
2015
Q4
$5.9M Hold
70,000
0.05% 273
2015
Q3
$5.86M Hold
70,000
0.04% 244
2015
Q2
$5.84M Hold
70,000
0.03% 325
2015
Q1
$5.09M Buy
+70,000
New +$4.98M 0.03% 362

Other funds holding LLY

Commerzbank Aktiengesellschaft's LLY Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $4.71M and leaving 32,580 shares worth $30M. The position accounts for 0.63% of the portfolio, ranked #34.

Commerzbank Aktiengesellschaft first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $40M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Commerzbank Aktiengesellschaft held 32,580 shares of Eli Lilly worth $30M as of Q1 2026.
  • Commerzbank Aktiengesellschaft sold 4,645 Eli Lilly shares in Q1 2026, an estimated $4.71M.
  • Eli Lilly made up 0.63% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #34 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • Commerzbank Aktiengesellschaft's Eli Lilly position peaked at $40M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.